Febuxostat, a Xanthine Oxidoreductase Inhibitor, Decreases NLRP3-dependent Inflammation in Macrophages by Activating the Purine Salvage Pathway and Restoring Cellular Bioenergetics

Johji Nomura(Teijin (Japan)), Nathalie Busso(University of Lausanne)

Scientific Reports

November 21, 2019

10.1038/s41598-019-53965-x

Cited by 44

Related Papers

Febuxostat, an Inhibitor of Xanthine Oxidase, Suppresses Lipopolysaccharide-Induced MCP-1 Production via MAPK Phosphatase-1-Mediated Inactivation of JNK

|PLoS ONE|2013|83